Kinevant
  • Home
  • About Us
  • Sarcoidosis
  • Research
    • Mechanism
    • Mechanism
    • Namilumab
    • Clinical Trials
  • News
  • Careers
  • Contact
Select Page

News

About Us - Kinevant
11.17.2022
Press Release

Kinevant Sciences Announces First Patient Dosed in Phase 2 Study of Namilumab for the Treatment of Pulmonary Sarcoidosis (RESOLVE-Lung)

Read More
08.29.2022
Podcast

Sarc Fighter: Living with Sarcoidosis and other rare diseases

Listen on Apple Podcasts
Listen on Spotify

Kinevant Sciences, Inc.
151 W 42nd Street
New York, NY 10036

Email: info@kinevant.com

  • Home
  • About Us
  • Sarcoidosis
  • Research
  • Careers
  • Contact Us
©2023 Kinevant Sciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Terms of Use

Site Design: Monderer Design